FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved Sandoz Inc's amoxicillin/clavulanate potassium as an Original Application (ANDA), granting approval for a generic antibiotic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Community-acquired Pneumonia
• Intra-abdominal Infections
• Otitis Media
• Pyelonephritis
• Skin and Skin Structure Infections
• Uncomplicated Urinary Tract Infection

Drugs mentioned

• AMOXICILLIN AND CLAVULANATE POTASSIUM (amoxicillin and clavulanate potassium)

Snippet

ORIG AP for AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN AND CLAVULANATE POTASSIUM)